Dr. Edward R. Maharam, MD

Dr. Maharam practices at AdventHealth Orlando in Orlando, Florida, part of AdventHealth.

Dr. Maharam's NPI, 1538504204, was assigned on May 7, 2013. Dr. Maharam graduated from FIU Herbert Wertheim College of Medicine in 2013. Dr. Maharam holds Florida license ME140421.

Dr. Maharam's primary practice is AdventHealth Orlando, at 601 E Rollins St, Orlando, FL 32803 in Orange County. The practice phone is (407) 303-1976.

Dr. Maharam's primary practice is AdventHealth Orlando in Orlando, Florida, part of AdventHealth. The medical group on file is AdventHealth Medical Group. Dmand AI also links Dr. Maharam to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Maharam practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Maharam's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Maharam is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Maharam's licenses on file in 5 states: Florida, California, Tennessee, Arizona and New York.

Dmand AI lists acute diabetes, acute respiratory failure, acute skin infection, cardiac arrhythmia, chronic diabetes, chronic hypertension, cirrhosis and congestive heart failure among the conditions Dr. Maharam treats.

CMS data shows 546 Medicare services from Dr. Maharam across 7 procedure codes in 2024, for 223 Medicare patients. Medicare paid $36,847 for them.

CMS counts 223 Medicare patients who saw Dr. Maharam in 2024. The largest group is 65 to 74, with 80 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 2.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Maharam's median patient age at 60, with 56% women.

In 2024, Dr. Maharam wrote 263 Medicare Part D claims for 113 patients. 86% of them were for generic drugs. CMS names the drug for 54 of them, across 4 drugs with 11 or more claims each, at $193 in total drug cost. In 2023, CMS named 668 claims across 27 drugs.

Dr. Maharam accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Maharam as offering telehealth.

Dmand AI links 6 papers to Dr. Maharam, published from 2009 to 2025. Dr. Maharam has published most often in Cureus. Dr. Maharam's most frequent co-authors are George Douglas Everett, MD, Jonathan Young Lee, MD and Peter J. Taub, MD.

CMS Open Payments shows 3 general payments to Dr. Maharam from 3 drug and device companies from 2016 to 2020. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $125.

Dr. Maharam graduated from FIU Herbert Wertheim College of Medicine in 2013.

Dr. Maharam is in network with 10 carriers, including Elevance, Cigna and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.